Israel, located in a region endemic for hepatitis A virus (HAW, recently absorbed a large population of immigrants who came from the former USSR. To assess the risk of high morbidity in this population a serosurvey of HAV antibodies was undertaken. Serum samples were collected from 965 new immigrant
Prevalence of Hepatitis E Antibodies in Immigrants from Developing Countries
✍ Scribed by D. Tarragó; R. López-Vélez; C. Turrientes; F. Baquero; M. L. Mateos
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 51 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatitis E virus (HEV) is a very important public health concern in many developing countries where epidemics of hepatitis E are common. Sporadic cases of clinical hepatitis E not only occur in these countries but also occur uncommonly in patients with no known epidemiological exposure to HEV in in
Worldwide there is only limited information on the epidemiology of hepatitis E virus (HEV) and its association with other hepatotropic viruses. Endemic regions have been described in some Asian countries, whereas in Europe only sporadic cases have been reported. The prevalence of HEV and a series of
## Abstract Cases of autochthonous acute hepatitis E occur in most industrialized countries and are frequent in the South West of France. The prevalence of anti‐hepatitis E virus (HEV) IgG antibodies in blood donors in this area was determined. A total of 529 samples from rural and urban blood dono
In order to study the prevalence of antibody to hepatitis E virus (HEV) among hemodialysis patients and to evaluate whether chronic hemodialysis is associated with an increased risk of exposure to HEV in developed countries, the IgG anti-HEV was determined in serum samples obtained from 182 patients
## Abstract The prevalence of antibodies to hepatitis A (anti‐HA) was investigated in patients attending a clinic for hematological malignancies. Patients were divided into three age groups; the number with antibodies in each group was recorded. Of the 130 patients studied, 44% of those aged 4–26,